Cigna Group (CI) is undervalued and CVS Health Corp (CVS) is slightly overvalued.
Against our estimates of intrinsic value, CI trades at the wider discount: a margin of safety of +33%, against -10% for CVS.
Values as of the 22 Sept 2026 close.
Discounting its cash flows at 6.9% (average of 3 methods) values the shares at $406.00; the price of $273.74 is 33% below that value, and 84% of that value comes from beyond year five.
Leak Score 70/100 on 9 of 12 signals
Discounting its cash flows at 7.3% (average of 3 methods) values the shares at $79.35; the price of $87.10 is 10% above that value, and 82% of that value comes from beyond year five.
Leak Score 36/100 on 9 of 12 signals
| Metric | CI | CVS |
|---|---|---|
| Verdict | Undervalued | Slightly overvalued |
| Price | $273.74 | $87.10 |
| Intrinsic value | $406.00 | $79.35 |
| Margin of safety | +33% | -10% |
| Leak Score | 70/100 (9/12) | 36/100 (9/12) |
| Market cap | $72.3B | $111.4B |
| Revenue growth, 5 years | 11.3% | 8.4% |
| Operating margin | 3.9% | 3.5% |
| Net margin | 2.3% | 1.2% |
| Return on equity | 15.5% | 6.2% |
| Debt to equity | 0.75 | 0.96 |
| P/E | 11.3x | 23.0x |
| Forward P/E | 8.2x | 10.2x |
| P/B | 1.7x | 1.4x |
| Dividend yield | 2.3% | 3.1% |